Collins Stewart

Collins Stewart reduces its price target $3 to $8 on Cbeyond (NASDAQ: CBEY) on the company's uphill battles in both legacy and cloud services. Collins Stewart says, "In its legacy services, we believe competitive pressure continues to build as ILECs are putting efforts to defend their territories...

In a research report published earlier today by Collins Stewart, Level 3 Communications (NYSE: LVLT) FCF generation prospects all too often in disappointment, and the current one is no different. According to Collins Stewart, “With the prospects of actual FCF generation for Level 3 looming for the...

According to a research report published earlier today, Collins Stewart has downgraded Cablevision Systems Corp. (NYSE: CVC) from Buy to Hold. Collins Stewart commented in the report, “With lower 2012 (and out year) OCF and FCF est, our target declines from $30 to $16.50. Moreover, with the...

Collins Stewart reiterates its Neutral rating and $2 target price on Savient Pharmaceuticals (NASDAQ: SVNT) as it still waits for an inflection on the company's sales base. Collins Stewart says, "While patient referrals from the expanded physician base could lead to incremental uptake, we...

Collins Stewart reiterates its Sell rating and $12 target price on Amylin Pharmaceuticals (NASDAQ: AMLN) as Bydureon enters the market. Collins Stewart notes, "This morning, IMS released GLP-1 weekly prescription numbers for the week ending Feb 17th. Bydureon TRx for the week ending Feb 17 were...

According to a research report published today, Collins Stewart finds SBA Communications (NASDAQ: SBAC) to be a very attractive stock at the moment, even with a new twist. Collins Stewart commented in the report, “Although the revenue split model appears to be an obvious negative, we note that the...

Collins Stewart lowers its rating on Human Genome Sciences (NASDAQ: HGSI) to Neutral, as survey suggests lackluster performance in 2012. Target price is at $10. Collins Stewart says, "We are presenting the results of our 4Q11 Benlysta tracking survey (N=30), which suggests that 83% of physicians...

Collins Stewart reiterates its Neutral rating on Digital Realty Trust (NYSE: DLR) as it believes consolidation remains key to the company's ability to sustain solid performance in latest quarter. Collins Stewart raises its price target to $70 as it rolls its estimates forward. Collins Stewart...

Collins Stewart reiterates its Neutral rating and $11 price target on Cbeyond (NASDAQ: CBEY) following generally in-line results for Q4. Collins Stewart says, "Cbeyond reported PRELIMINARY results for the 4Q11 and full year late last week with full detailed results to be provided upon completion...

Collins Stewart lowers its rating on Leap Wireless International (NASDAQ: LEAP) in continued volatility in operating trends. Price target is also cut to $12 from $18. Collins Stewart says, "Following several volatile quarters of results and what appears to be increasing levels of competition,...

According to Collins Stewart, Equinix (NASDAQ: EQIX) price target is raised to $150. Collins Stewart said that despite heavier than expected FX headwind, Equinix reported solid results after the close last night with revenues of $431.3mm versus the expectations of $432.1mm and Street estimates of...

In a research report published earlier today by Collins Stewart, Incyte Corporation's (NASDAQ: INCY) 4Q11 total revenue of $28.9M was above consensus of $25.7M and CSe of $26.8M. Collins Stewart attributed much of the success to Jakafi: “Gross Jakafi revenue shipped to patients (INCY uses the sell...

According to a research report published today by Collins Stewart, Masimo Corporation's (NASDAQ: MASI) 4Q11 results provided initial 2012 guidance that were in line with consensus. In the report, Masimo explained further, “Following a couple quarters of downward revisions, we view this as a...

In a research report published this morning, Collins Stewart noted that SunEdison has positive business trends in CY12, maintaining its value for MEMC Electronic Materials Inc. (NYSE: WFR). In the report, Collins Stewart said, “The SunEdison division is forecast to post $471M of non-GAAP revenue...

Collins Stewart maintains its Neutral rating on Rackspace Hosting (NASDAQ: RAX) as it believes the company's solid quarter and outlook are largely priced in. It raises the price target on shares to $50, however, as it rolls estimates over to 2013. Collins Stewart says, "With strong secular...